The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma.

IF 3.4 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Journal of Gynecologic Oncology Pub Date : 2024-05-01 Epub Date: 2023-12-07 DOI:10.3802/jgo.2024.35.e24
Yusuke Toyohara, Kenbun Sone, Katsuhiko Noda, Kaname Yoshida, Shimpei Kato, Masafumi Kaiume, Ayumi Taguchi, Ryo Kurokawa, Yutaka Osuga
{"title":"The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma.","authors":"Yusuke Toyohara, Kenbun Sone, Katsuhiko Noda, Kaname Yoshida, Shimpei Kato, Masafumi Kaiume, Ayumi Taguchi, Ryo Kurokawa, Yutaka Osuga","doi":"10.3802/jgo.2024.35.e24","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Magnetic resonance imaging (MRI) is efficient for the diagnosis of preoperative uterine sarcoma; however, misdiagnoses may occur. In this study, we developed a new artificial intelligence (AI) system to overcome the limitations of requiring specialists to manually process datasets and a large amount of computer resources.</p><p><strong>Methods: </strong>The AI system comprises a tumor image filter, which extracts MRI slices containing tumors, and sarcoma evaluator, which diagnoses uterine sarcomas. We used 15 types of MRI patient sequences to train deep neural network (DNN) models used by tumor filter and sarcoma evaluator with 8 cross-validation sets. We implemented tumor filter and sarcoma evaluator using ensemble prediction technique with 9 DNN models. Ten tumor filters and sarcoma evaluator sets were developed to evaluate fluctuation accuracy. Finally, AutoDiag-AI was used to evaluate the new validation dataset, including 8 cases of sarcomas and 24 leiomyomas.</p><p><strong>Results: </strong>Tumor image filter and sarcoma evaluator accuracies were 92.68% and 90.50%, respectively. AutoDiag-AI with the original dataset accuracy was 89.32%, with 90.47% sensitivity and 88.95% specificity, whereas AutoDiag-AI with the new validation dataset accuracy was 92.44%, with 92.25% sensitivity and 92.50% specificity.</p><p><strong>Conclusion: </strong>Our newly established AI system automatically extracts tumor sites from MRI images and diagnoses them as uterine sarcomas without human intervention. Its accuracy is comparable to that of a radiologist. With further validation, the system could be applied for diagnosis of other diseases. Further improvement of the system's accuracy may enable its clinical application in the future.</p>","PeriodicalId":15868,"journal":{"name":"Journal of Gynecologic Oncology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11107276/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gynecologic Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3802/jgo.2024.35.e24","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Magnetic resonance imaging (MRI) is efficient for the diagnosis of preoperative uterine sarcoma; however, misdiagnoses may occur. In this study, we developed a new artificial intelligence (AI) system to overcome the limitations of requiring specialists to manually process datasets and a large amount of computer resources.

Methods: The AI system comprises a tumor image filter, which extracts MRI slices containing tumors, and sarcoma evaluator, which diagnoses uterine sarcomas. We used 15 types of MRI patient sequences to train deep neural network (DNN) models used by tumor filter and sarcoma evaluator with 8 cross-validation sets. We implemented tumor filter and sarcoma evaluator using ensemble prediction technique with 9 DNN models. Ten tumor filters and sarcoma evaluator sets were developed to evaluate fluctuation accuracy. Finally, AutoDiag-AI was used to evaluate the new validation dataset, including 8 cases of sarcomas and 24 leiomyomas.

Results: Tumor image filter and sarcoma evaluator accuracies were 92.68% and 90.50%, respectively. AutoDiag-AI with the original dataset accuracy was 89.32%, with 90.47% sensitivity and 88.95% specificity, whereas AutoDiag-AI with the new validation dataset accuracy was 92.44%, with 92.25% sensitivity and 92.50% specificity.

Conclusion: Our newly established AI system automatically extracts tumor sites from MRI images and diagnoses them as uterine sarcomas without human intervention. Its accuracy is comparable to that of a radiologist. With further validation, the system could be applied for diagnosis of other diseases. Further improvement of the system's accuracy may enable its clinical application in the future.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
子宫肉瘤术前磁共振成像自动诊断人工智能系统。
目的:磁共振成像(MRI)可有效诊断术前子宫肉瘤,但可能会出现误诊。在这项研究中,我们开发了一种新的人工智能(AI)系统,以克服需要专家手动处理数据集和大量计算机资源的局限性:该人工智能系统由肿瘤图像过滤器和肉瘤评估器组成,前者用于提取含有肿瘤的磁共振成像切片,后者用于诊断子宫肉瘤。我们使用 15 种核磁共振成像患者序列训练深度神经网络(DNN)模型,肿瘤过滤器和肉瘤评估器使用 8 组交叉验证。我们使用集合预测技术和 9 个 DNN 模型实现了肿瘤过滤器和肉瘤评估器。我们开发了 10 个肿瘤过滤器和肉瘤评估器集来评估波动准确性。最后,AutoDiag-AI 被用来评估新的验证数据集,包括 8 例肉瘤和 24 例子宫肌瘤:结果:肿瘤图像过滤器和肉瘤评估器的准确率分别为 92.68% 和 90.50%。使用原始数据集的 AutoDiag-AI 的准确率为 89.32%,灵敏度为 90.47%,特异度为 88.95%;而使用新验证数据集的 AutoDiag-AI 的准确率为 92.44%,灵敏度为 92.25%,特异度为 92.50%:结论:我们新建立的人工智能系统能自动从核磁共振图像中提取肿瘤部位并诊断为子宫肉瘤,无需人工干预。其准确性可与放射科医生媲美。经过进一步验证,该系统可应用于其他疾病的诊断。进一步提高该系统的准确性可使其在未来应用于临床。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Gynecologic Oncology
Journal of Gynecologic Oncology ONCOLOGY-OBSTETRICS & GYNECOLOGY
CiteScore
6.00
自引率
2.60%
发文量
84
审稿时长
>12 weeks
期刊介绍: The Journal of Gynecologic Oncology (JGO) is an official publication of the Asian Society of Gynecologic Oncology. Abbreviated title is ''J Gynecol Oncol''. It was launched in 1990. The JGO''s aim is to publish the highest quality manuscripts dedicated to the advancement of care of the patients with gynecologic cancer. It is an international peer-reviewed periodical journal that is published bimonthly (January, March, May, July, September, and November). Supplement numbers are at times published. The journal publishes editorials, original and review articles, correspondence, book review, etc.
期刊最新文献
Step-by-step demonstration of "sciatic-nerve-preserved beyond-LEER" in a Thiel-embalmed cadaver: a novel salvage surgery for recurrent gynecologic malignancies. Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study. Anticancer effect of the antipsychotic agent penfluridol on epithelial ovarian cancer. Attitudes toward subsequent primary cancer prevention among survivors of childhood, adolescent, and young adult (CAYA) cancer in Japan: results of a comprehensive questionnaire survey on long-term women's health after CAYA cancer. Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1